These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23132723)
1. Candidate mucosal vaccine against hepatitis B based on tomatoes transgenic for the preS2-S gene. Salyaev RK; Rekoslavskaya NI; Stolbikov AS; Tret'yakova AV Dokl Biochem Biophys; 2012; 446():257-9. PubMed ID: 23132723 [No Abstract] [Full Text] [Related]
2. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease. Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560 [TBL] [Abstract][Full Text] [Related]
3. Obtaining tomato plants transgenic for the preS2-S-HDEL gene, which synthesize the major hepatitis B surface antigen. Salyaev RK; Stolbikov AS; Rekoslavskaya NI; Shchelkunov SN; Pozdnyakov SG; Chepinoga AV; Hammond RV Dokl Biochem Biophys; 2010; 433():187-90. PubMed ID: 20714853 [No Abstract] [Full Text] [Related]
4. [Designing of a candidate edible vaccine against hepatitis B and HIV on the basis of a transgenic tomato]. Shchelkunov SN; Saliaev RK; Ryzhova TS; Pozdniakov SG; Nesterov AE; Rekoslavskaia NI; Sumtsova VM; Pakova NV; Mishutina UO; Kopytina TV; Hammond RV Vestn Ross Akad Med Nauk; 2004; (11):50-5. PubMed ID: 15651666 [TBL] [Abstract][Full Text] [Related]
5. [Immunological and virological efficacy against HBV chronic infection of the therapeutic vaccine composed of HBV core plus PreS1 in HBV transgenic mice]. Li MZ; Chen XC; Zhou BP; Le XH; Xu LM; Wang HS Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):277-9. PubMed ID: 15340577 [TBL] [Abstract][Full Text] [Related]
6. [Persistence of immunity after hepatitis B vaccination]. Madaliński K Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586 [TBL] [Abstract][Full Text] [Related]
7. Do we need better hepatitis B vaccines? Gerlich WH Indian J Med Res; 2017 Apr; 145(4):414-419. PubMed ID: 28862172 [No Abstract] [Full Text] [Related]
8. Synthesis of hepatitis B virus surface antigen in tomato plants transgenic for the preS2-S gene. Salyaev K; Rekoslavskaya NI; Stolbikov AS; Hammond RW; Shchelkunov SN Dokl Biochem Biophys; 2007; 416():290-3. PubMed ID: 18064835 [No Abstract] [Full Text] [Related]
9. Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B? Gehring S; Pietrzak-Nguyen A; Fichter M; Landfester K Nanomedicine (Lond); 2017 Jun; 12(11):1205-1207. PubMed ID: 28517963 [No Abstract] [Full Text] [Related]
11. Expression of the hepatitis B surface S and preS2 antigens in tubers of Solanum tuberosum. Joung YH; Youm JW; Jeon JH; Lee BC; Ryu CJ; Hong HJ; Kim HC; Joung H; Kim HS Plant Cell Rep; 2004 Jul; 22(12):925-30. PubMed ID: 15048583 [TBL] [Abstract][Full Text] [Related]
12. Boosting immune response to hepatitis B DNA vaccine by coadministration of Prothymosin alpha-expressing plasmid. Jin Y; Cao C; Li P; Liu X; Huang W; Li C; Ma Q Clin Diagn Lab Immunol; 2005 Dec; 12(12):1364-9. PubMed ID: 16339058 [TBL] [Abstract][Full Text] [Related]
13. In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site. Cupps TR; Tibbles J; Hurni WM; Miller WJ; Ellis RW; Milich D; Wetter N J Immunol; 1993 Sep; 151(6):3353-60. PubMed ID: 7690803 [TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of tomato (Lycopersicum esculentum var. cerasifarm) expressing the HBsAg gene by 2-dimensional difference gel electrophoresis. Guo B; He W; Wu D; Che D; Fan P; Xu L; Wei Y Plant Foods Hum Nutr; 2013 Dec; 68(4):424-9. PubMed ID: 24057504 [TBL] [Abstract][Full Text] [Related]
16. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Richter LJ; Thanavala Y; Arntzen CJ; Mason HS Nat Biotechnol; 2000 Nov; 18(11):1167-71. PubMed ID: 11062435 [TBL] [Abstract][Full Text] [Related]
17. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus. Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132 [TBL] [Abstract][Full Text] [Related]
18. Study of immunogenic properties of the candidate edible vaccine against human immunodeficiency and hepatitis B viruses based on transgenic tomato fruits. Shchelkunov SN; Salyaev RK; Rekoslavskaya NI; Pozdnyakov SG; Nesterov AE; Sumtsova VM; Pakova NV; Mishutina UO; Kopytina TV; Hammond R Dokl Biochem Biophys; 2005; 401():167-9. PubMed ID: 15999829 [No Abstract] [Full Text] [Related]
19. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Huang Z; Elkin G; Maloney BJ; Beuhner N; Arntzen CJ; Thanavala Y; Mason HS Vaccine; 2005 Mar; 23(15):1851-8. PubMed ID: 15734055 [TBL] [Abstract][Full Text] [Related]
20. [Oral vaccines--a future prospect! Hepatitis vaccination in the vegetable market?]. Stiefelhagen P MMW Fortschr Med; 2003 Nov; 145(47):10. PubMed ID: 14725025 [No Abstract] [Full Text] [Related] [Next] [New Search]